ReviewMicrobial cell (Graz, Austria)2018
Methodologies for
Open access · goldAbstract readReview
In one paragraph
Review in Microbial cell (Graz, Austria), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.
0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
64 citing papers in PubMed, 120 citations in OpenAlex.
- Randomised-crossover clinical trial on the substantivity of a single application of a gel containing chlorhexidine and o-cymen-5-ol on the oral biofilm and saliva.BMC oral health · 2024Trial
- Chemical Composition and Biological Activities of Geopropolis From Four Melipona Species From the Brazilian Atlantic Forest.Chemistry & biodiversity · 2026Article
- Antibiofilm efficacy of 1,064-nm neodymium-doped yttrium aluminum garnet laser onMicrobiology spectrum · 2026Article
- Artificial Intelligence-Based In Silico Evaluation of the Pharmacological Potential and In Vitro Anti-Malignancy Effect in the Human Glioblastoma Cell Line of the Hydrate of the Coumarin Compound Meranzin Originating From the Edible Macroalga (Food science & nutrition · 2026Article
- Determination of the Lethal Concentrations of Two Phenolic Acid Derivatives Originated From the Edible Red Marine Macroalga (Food science & nutrition · 2026Article
- Development and characterization of fenticonazole nitrate-loaded cubogel for the management of vaginal candidiasis.International journal of pharmaceutics: X · 2025Article
- Computational Approaches for Discovering Virulence Factors inJournal of fungi (Basel, Switzerland) · 2025Review
- Biological evaluation and molecular docking studies of novel aza-acyclic nucleosides as putative antimicrobial, anticancer, and antioxidant agents.BMC chemistry · 2025Article
- Dermatophytosis in context of Trichophyton rubrum: host defense mechanisms, virulence factors, and treatment innovations.Molecular biology reports · 2025Review
- Chemical profile, antioxidant, antifungal, and cytotoxic activities of propolis from the stingless bee Tetragona clavipes.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025Article
- Innovative dual-functional hybrid cationic PEGylated proniosomes as a smart nano-platform for Boosted vaginal delivery: multi-levelFrontiers in pharmacology · 2025Article
- Combinations of posaconazole and tacrolimus are effective against infections with azole-resistantFrontiers in cellular and infection microbiology · 2025Article
- Azole Combinations and Multi-Targeting Drugs That Synergistically InhibitJournal of fungi (Basel, Switzerland) · 2024Review
- Chiral Fluorescent Antifungal Azole Probes Detect Resistance, Uptake Dynamics, and Subcellular Distribution inJACS Au · 2024Article
- New thymol-derived triazole exhibits promising activity against Trichophyton rubrum.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Synergistic activity of gold nanoparticles with amphotericin B on persister cells of Candida tropicalis biofilms.Journal of nanobiotechnology · 2024Article
- Impact of Nitric Oxide-Release Kinetics on Antifungal Activity.Journal of fungi (Basel, Switzerland) · 2024Article
- Antibiofilm Activity and Biocompatibility of Temporin-SHa: A Promising Antimicrobial Peptide for Control of Fluconazole-ResistantMicroorganisms · 2024Article
- Antibiofilm activity of marine microbial natural products: potential peptide- and polyketide-derived molecules from marine microbes toward targeting biofilm-forming pathogens.Journal of natural medicines · 2024Review
- Quantification methods ofMicrobial cell (Graz, Austria) · 2024Article
4 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
39 authors at 20 institutions in 11 countries.
Patrick Van DijckVIB-KU Leuven Center for Microbiology, Leuven, Belgium.
Jelmer SjollemaUniversity of Groningen, University Medical Center Groningen, Department of BioMedical Engineering, Groningen, The Netherlands.
Bruno P CammueCentre for Microbial and Plant Genetics, KU Leuven, Leuven, Belgium.
Katrien LagrouDepartment of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
Judith BermanSchool of Molecular Cell Biology and Biotechnology, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel.
Christophe d'EnfertInstitut Pasteur, INRA, Unité Biologie et Pathogénicité Fongiques, Paris, France.
David R AndesDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Maiken C ArendrupUnit of Mycology, Statens Serum Institut, Copenhagen, Denmark.
Axel A BrakhageLeibniz Institute for Natural Product Research and Infection Biology - Hans Knoell Institute (HKI), Dept. Microbiology and Molecular Biology, Friedrich Schiller University Jena, Institute of Microbiology, Jena, Germany.
Richard CalderoneDepartment of Microbiology & Immunology, Georgetown University Medical Center, Washington DC, USA.
Emilia CantónSevere Infection Research Group: Medical Research Institute La Fe (IISLaFe), Valencia, Spain.
Tom CoenyeLaboratory of Pharmaceutical Microbiology, Ghent University, Ghent, Belgium.
Paul CosLaboratory for Microbiology, Parasitology and Hygiene (LMPH), University of Antwerp, Belgium.
Leah E CowenDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Mira EdgertonDepartment of Oral Biology, School of Dental Medicine, University at Buffalo, Buffalo, NY USA.
Ana Espinel-IngroffVCU Medical Center, Richmond, VA, USA.
Scott G FillerDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
Mahmoud GhannoumCenter for Medical Mycology, Department of Dermatology, University Hospitals Cleveland Medical Center and Case Western Re-serve University, Cleveland, OH, USA.
Neil A R GowMRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.
Hubertus HaasBiocenter - Division of Molecular Biology, Medical University Innsbruck, Innsbruck, Austria.
Mary Ann Jabra-RizkDepartment of Oncology and Diagnostic Sciences, School of Dentistry; Department of Microbiology and Immunology, School of Medicine, University of Maryland, Baltimore, USA.
Elizabeth M JohnsonNational Infection Service, Public Health England, Mycology Reference Laboratory, Bristol, UK.
Shawn R LockhartCenters for Disease Control and Prevention, Atlanta, GA, USA.
Jose L Lopez-RibotCenters for Disease Control and Prevention, Atlanta, GA, USA.
Johan MaertensDepartment of Microbiology and Immunology, KU Leuven, Leuven, Belgium and Clinical Department of Haematology, UZ Leuven, Leuven, Belgium.
Carol A MunroMRC Centre for Medical Mycology, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.
Jeniel E NettUniversity of Wisconsin-Madison, Departments of Medicine and Medical Microbiology & Immunology, Madison, WI, USA.
Clarissa J NobileDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, Merced, USA.
Michael A PfallerDepartments of Pathology and Epidemiology, University of Iowa, Iowa, USA.
Gordon RamageESCMID Study Group for Biofilms, Switzerland.
Dominique SanglardInstitute of Microbiology, University of Lausanne and University Hospital, CH-1011 Lausanne.
Maurizio SanguinettiInstitute of Microbiology, Università Cattolica del Sacro Cuore, IRCCS-Fondazione Policlinico "Agostino Gemelli", Rome, Italy.
Isabel SprietPharmacy Dpt, University Hospitals Leuven and Clinical Pharmacology and Pharmacotherapy, Dpt. of Pharmaceutical and Pharma-cological Sciences, KU Leuven, Belgium.
Paul E VerweijCenter of Expertise in Mycology Radboudumc/CWZ, Radboud University Medical Center, Nijmegen, the Netherlands (omit "Nijmegen" in Radboud University Medical Center).
Adilia WarrisMRC Centre for Medical Mycology, Aberdeen Fungal Group, University of Aberdeen, Foresterhill, Aberdeen, UK.
Joost WautersKU Leuven-University of Leuven, University Hospitals Leuven, Department of General Internal Medicine, Herestraat 49, B-3000 Leuven, Belgium.
Michael R YeamanGeffen School of Medicine at the University of California, Los Angeles, Divisions of Molecular Medicine & Infectious Diseases, Har-bor-UCLA Medical Center, LABioMed at Harbor-UCLA Medical Center.
Sebastian A J ZaatDepartment of Medical Microbiology, Amsterdam Infection and Immunity Institute, Academic Medical Center, University of Am-sterdam, Netherlands.
Karin ThevissenCentre for Microbial and Plant Genetics, KU Leuven, Leuven, Belgium.
KU Leuven · BEUniversity of Aberdeen · GBUniversity of Wisconsin–Madison · USAcademic Medical Center · NLCanada Research Chairs · CACase Western Reserve University · USCenters for Disease Control and Prevention · USEuropean Society of Clinical Microbiology and Infectious Diseases · CHFriedrich Schiller University Jena · DEGeorgetown University · USHarbor–UCLA Medical Center · USInnsbruck Medical University · ATJMI Laboratories · USPublic Health England · GBRadboud University Nijmegen · NLStatens Serum Institut · DKTel Aviv University · ILThe University of Texas at San Antonio · USUCLA Medical Center · USUniversità Cattolica del Sacro Cuore · IT
Funding
Supplements to Support Candida DNA Microarray FacilitiesR01DE010641 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI EDGERTON, MIRA · 2000 to 2019
$6.7MC. albicans invasion and proliferation during oral infectionR01DE026600 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2017 to 2021
$3.0MEndothelial invasion by yeast-phase CandidaR01AI124566 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2016 to 2020
$2.7MGenetic regulation of inter- and intra-species microbial community formationR35GM124594 · NIGMS · UNIVERSITY OF CALIFORNIA, MERCED · PI NOBILE, CLARISSA JANE · 2017 to 2021
$2.0MRegulation of Sexual Biofilm Development in Candida albicansR21AI125801 · NIAID · UNIVERSITY OF CALIFORNIA, MERCED · PI NOBILE, CLARISSA JANE · 2017 to 2018
$503kMedical Research Council MR/N006364/1NIAID NIH HHS R01 AI124566NIAID NIH HHS R21 AI125801NIDCR NIH HHS R01 DE010641NIDCR NIH HHS R01 DE026600NIGMS NIH HHS R35 GM124594Wellcome Trust
Abstract
Unlike superficial fungal infections of the skin and nails, which are the most common fungal diseases in humans, invasive fungal infections carry high morbidity and mortality, particularly those associated with biofilm formation on indwelling medical devices. Therapeutic management of these complex diseases is often complicated by the rise in resistance to the commonly used antifungal agents. Therefore, the availability of accurate susceptibility testing methods for determining antifungal resistance, as well as discovery of novel antifungal and antibiofilm agents, are key priorities in medical mycology research. To direct advancements in this field, here we present an overview of the methods currently available for determining (i) the susceptibility or resistance of fungal isolates or biofilms to antifungal or antibiofilm compounds and compound combinations; (ii) the
Indexed as
antibiofilm material coatingantifungal susceptibility testingbiofilm eradicationbiofilm inhibitionin vivo models
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.